Strata Critical Medical (SRTA) Short-term Investments (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Short-term Investments data on file, last reported at $66000.0 in Q1 2026.

• Quarterly Short-term Investments fell 99.92% year-over-year to $66000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66000.0 (down 99.92% YoY) and the FY2025 annual result came in at $30.3 million, down 72.17% from the prior year.
• Short-term Investments slipped to $66000.0 in Q1 2026 per SRTA's latest filing, from $30.3 million in the prior quarter.
• Across five years, Short-term Investments topped out at $266.6 million in Q1 2022 and bottomed at $66000.0 in Q1 2026.
• The 5-year median for Short-term Investments is $115.6 million (2024), against an average of $109.3 million.
• The widest annual swing landed in 2022, when Short-term Investments jumped 10948.73%; it then tumbled 99.92% in 2026.
• Tracing SRTA's Short-term Investments over 5 years: stood at $150.7 million in 2022, then retreated by 8.28% to $138.3 million in 2023, then slipped by 21.34% to $108.8 million in 2024, then slumped by 72.17% to $30.3 million in 2025, then tumbled by 99.78% to $66000.0 in 2026.
• Per Business Quant, the three latest SRTA Short-term Investments figures stand at $66000.0 (Q1 2026), $30.3 million (Q4 2025), and $53.2 million (Q3 2025).

Peer Comparison